Mustargen Used to Treat Pleural Effusion
Mustargen® (mechlorethamine) is a chemotherapy drug used to treat a number of different types of cancer, such as lung cancer and several blood and bone marrow cancers. A healthcare provider may also prescribe Mustargen for use in people who have pleural effusion associated with certain metastatic cancers.
Metastatic cancer is cancer that has spread from its original site to other areas of the body. Pleural effusion occurs when excess fluid accumulates in the space between membranes that line body organs, such as the lungs or abdomen (stomach). In some cases, metastatic cancer may cause effusion, and cancer cells may be found in the excess fluid.
Mustargen is considered a palliative treatment, which means it helps reduce symptoms but does not cure the disease.
(To learn more about how this drug is used to treat pleural effusion, click Mustargen Uses. This full-length article takes a closer look at this chemotherapy drug, including details on how it works and whether it is safe for older adults and children.)